SevenBridge Financial Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

SevenBridge Financial Group’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-427	Closed	-$23K	–	663
2017 Q4	$23K	Sell	427 -100	-19%	-$5.47K	0.01%	359
2017 Q3	$30K	Sell	527 -19	-3%	-$1.11K	0.02%	322
2017 Q2	$33K	Hold	546	–	–	0.02%	321
2017 Q1	$31K	Buy	+546	New	+$26.9K	0.02%	319

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

SevenBridge Financial Group's BIVV Position: Q1 2018 in Review

SevenBridge Financial Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 427 shares — an estimated $23K sold.

SevenBridge Financial Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $33K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

SevenBridge Financial Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
SevenBridge Financial Group sold 427 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $23K.
SevenBridge Financial Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
SevenBridge Financial Group's Bioverativ Inc. Common Stock position peaked at $33K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on SevenBridge Financial Group's 13F filing for Q1 2018, filed 11 May 2018.